Onset of exercise training 14 days after uncomplicated myocardial infarction: a randomized controlled trial

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Inger-Lise AamotAsbjørn Støylen

Abstract

Exercise training is an important part of cardiac rehabilitation to reduce morbidity and mortality. Low-intensity exercise training can start as soon as the myocardial infarction (MI) patient is stable. Our objective was to evaluate the effect of an early start of exercise training in MI patients. A randomized controlled trial. Thirty-nine MI patients were randomized to either an early start of exercise training group (EG) or to a delayed start control group (CG). The EG participated in an outpatient low-intensity EG (phase 2a) two times a week for 4 weeks before entering ordinary exercise training of moderate-to-high intensity (phase 2b). CG entered phase 2b directly after 4 weeks of delay. Primary outcome measure was peak oxygen consumption (VO2peak), measured at baseline, after 4 weeks and after 16 weeks. Secondary outcome measure was health-related quality of life. VO2peak did not change from baseline to 4 weeks, either in EG [30.6+/-6.7 ml/kg/min vs. 30.7+/-6.2 ml/kg/min, not significant (NS)] or CG (29.8+/-6.1 ml/kg/min vs. 30.7+/-6.2 ml/kg/min, NS). After 16 weeks VO2peak increased in both groups to 33.1+/-7.1 ml/kg/min in EG (P<0.005) and 33.0 ml/kg/min+/-8.6 in CG (P<0.005), group differences NSH. Health-related qualit...Continue Reading

References

Jan 1, 1982·Medicine and Science in Sports and Exercise·G A Borg
Jul 1, 1995·Journal of Cardiopulmonary Rehabilitation·R H DressendorferG C Timmis
Dec 22, 2000·Spine·J E Ware
Sep 22, 2001·The New England Journal of Medicine·P A Ades
Mar 15, 2002·The New England Journal of Medicine·Jonathan MyersJ Edwin Atwood
May 23, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Tracy DixonNeil B Oldridge
Jul 20, 2002·Medicine and Science in Sports and Exercise·David P Swain, Barry A Franklin
Oct 3, 2002·Circulation·Raymond J GibbonsUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Ex
Feb 5, 2003·Scandinavian Journal of Clinical and Laboratory Investigation·J I MedbøR Stokke
Aug 2, 2003·Heart & Lung : the Journal of Critical Care·Lee-Anne GassnerNeil Piller
Dec 10, 2003·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·P GiannuzziUNKNOWN Working Group on Cardiac Rehabilitation and Exercise Physiology. European Society of Cardiology
Dec 13, 2003·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·UNKNOWN Vestfold Heartcare Study Group
Feb 27, 2004·International Journal of Sports Medicine·P U LarssonK B Henriksson-Larsén
Jun 5, 2004·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Øivind RognmoStig A Slørdahl
Jan 18, 2006·The Medical Journal of Australia·Tom G BriffaUNKNOWN National Heart Foundation of Australia

❮ Previous
Next ❯

Citations

Apr 1, 2011·European Journal of Preventive Cardiology·Nicola RussoAngelo Avogaro
Apr 25, 2013·European Journal of Preventive Cardiology·Inger-Lise AamotAsbjørn Støylen
Feb 22, 2012·European Journal of Preventive Cardiology·Nathaly Rius-OttenheimErik J Giltay
Apr 17, 2012·Annals of Rehabilitation Medicine·Chul KimYong Bum Park
Feb 1, 2019·Heart·Aynsley CowieUNKNOWN British Association for Cardiovascular Prevention and Rehabilitation (BACPR)

❮ Previous
Next ❯

Software Mentioned

Metamax
Metasoft

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.